$3.38 -0.02 (-0.59%)
11/6/2009 4:00 PM

Nabi Biopharmaceuticals (NABI)

CAPS Rating: 5 out of 5

The Company leverage its experience and knowledge in powering the human immune system to develop and market products that target serious medical conditions in the areas of transplantation, infectious disease and hematology/oncology.

Current Price $3.38 Mkt Cap $171.57M
Open $3.34 P/E Ratio 0.00
Prev. Close $3.40 Div. (Yield) N/A (N/A)
Daily Range $3.32 - $3.48 Volume 143,902
52-Wk Range $2.15 - $4.75 Avg. Daily Vol. 186,000

NABI News and Commentary

Caps

How do you think NABI will perform vs the S&P 500?

Add Stock to Watchlist

All Members

151 Outperform
8 Underperform
 

All-Star Members

35 Outperform
0 Underperform
 

Wall Street

1 Outperform
1 Underperform
 

Top NABI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

pjani06 (98.23)
Submitted July 23, 2009

outperform. company is HIGH in cash. not terribly overvalued, and is likely to kill S&P 500 where it is at today's levels.
additionally these companies are not within the financials nor energy sectors.

0 Comments | Reply | Report this Post

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NABI VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about NABI.

Recs

0
Member Avatar jjdonnelly (37.97) Submitted: 10/12/2009 7:25:54 PM : Outperform Start Price: $3.70 NABI Score: -8.41

The company is developing a nicotine vaccine. I think they will do well with it in the long term.

Report this Post 0 Comments | Reply | Permalink

Recs

1
Member Avatar pjani06 (98.23) Submitted: 7/23/2009 6:56:34 PM : Outperform Start Price: $2.41 NABI Score: +29.51

outperform. company is HIGH in cash. not terribly overvalued, and is likely to kill S&P 500 where it is at today's levels.
additionally these companies are not within the financials nor energy sectors.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar JohanHansen (72.65) Submitted: 6/12/2009 11:23:33 AM : Outperform Start Price: $2.78 NABI Score: +7.01

Turned around after 27% plus loss

Report this Post 0 Comments | Reply | Permalink
View All 14 Pitches »

Leaderboard

Find the members with the highest scoring picks in NABI.

Score Leader

pdt24

pdt24 (< 20) Score: +46.83

The Score Leader is the member with the highest score across all their picks in NABI.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
CaptBS 95.86 7/20/2009 Outperform 3Y $2.31 +46.32% +13.15% +33.17
nelsonrocky < 20 12/15/2006 Underperform 3M $7.14 -52.66% -20.40% +32.27
11Below3 < 20 5/16/2006 Underperform 5Y $5.94 -43.10% -11.28% +31.81
arviragus 99.22 7/13/2009 Outperform 1Y $2.23 +51.57% +21.89% +29.68
jmbalter 89.76 7/10/2009 Outperform 5Y $2.22 +52.25% +22.74% +29.51
pjani06 98.23 7/24/2009 Outperform 5Y $2.41 +40.25% +10.74% +29.51 1 Comment
Bucks1977 67.77 7/14/2009 Outperform 3M $2.31 +46.31% +18.98% +27.33
PrashantJain < 20 7/16/2009 Outperform 3Y $2.39 +41.42% +15.37% +26.06
ebowles48 26.25 8/8/2007 Outperform 3Y $3.33 +1.50% -24.01% +25.51
hotdatilpepper 32.37 8/6/2009 Outperform 5Y $2.57 +31.52% +6.71% +24.81
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackDawsonJames 29.19 9/17/2007 Outperform NS $4.19 -19.33% -23.96% +4.63
TrackJimCramer < 20 4/2/2007 Underperform 3W $5.21 -35.12% -20.33% +14.79

Featured Broker Partners